At-The-Market Issuance Sales AgreementAt-the-Market Issuance Sales Agreement • October 3rd, 2024 • Alzamend Neuro, Inc. • Pharmaceutical preparations • New York
Contract Type FiledOctober 3rd, 2024 Company Industry JurisdictionAlzamend Neuro, Inc., a Delaware corporation (the Company”), confirms its agreement (this “Agreement”) with Ascendiant Capital Markets, LLC (the “Agent”), as follows: